Health Reading List | August 21, 2015 |
Startup Highlight: Ixchel Scientific
YC Demo Day was this week, and there were a surprising number of health care companies. In my mind, the coolest by far was Ixchel, which promises to predict how drugs will react in the human body (specifically for cancer drugs). Many companies are attacking the space (read about the Flatiron/Guardant Health Partnership here), but I'll be excited to see the progress Ixchel makes in the field. It could mean billions in savings around R&D spend.
As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro. | Tomorrow, Today. Connecting Investors with the Hottest Startups this September 21-23 in San Francisco.  TechCrunch Disrupt is the most anticipated tech event of the year coming to San Francisco this September 21-23. Come for the fireside chats with thought leaders and panels on hot tech topics, a stroll through Startup and Hardware Alley, and the iconic Startup Battlefield competition. Leave knowing you’re one step ahead of the future. #TCDisrupt Take $1000 off your ticket today. | | Genetic testing is obviously blowing up, and Illumina is making a big bet with Helix on creating a "pay-as-you-go" model for gene sequencing to lower costs even further. Check out the full review. | | Jonathan Libov & Angela Tran Kingyens - On Digital Healthcare Jonathan Libov of USV and Angela Tran King of Version One are coming together to do a 6 part series on digital health. The first two parts are already up, and I was impressed with their Mobile Endpoints piece. I'm sure I'll be putting these up each week as they expand the series. | | And this week in CRISPR coverage... the Economist had a long overview of the technique, its implications, and companies chasing its power. Much of this probably won't be news to folks, but it's worth a read. | | People were super excited about 3D printed drugs... but synthetic DNA has the potential to change the game completely. Read about Synthorx and their work in the field here. | | Title says it all, this is a good listen on the way to work. I'll admit, I'm biased when it comes to content regarding collaboration in healthcare... so it's an important topic. | | Drew Boston, Marc Warren - Accenture Some fighting words from Accenture's Drew Boston and Marc Warren: half of the digital health start ups funded between 2008 and 2013 won't last more than 20 months (although not a crazy number when you think that 3/4 of start ups will fail). | | A review of kew trends in health care funding and private equity. Main trends include: urgent care, behavioral health, and dental practice management. Check out the entire report as well. | | | You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community. Startup Digest, © 2009-2015 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy. | | |
No comments:
Post a Comment